Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?

Although the prophylactic administration of indomethacin in extremely low-birth weight infants reduces the frequency of patent ductus arteriosus and severe intraventricular hemorrhage, it does not appear to provide any long-term benefit in terms of survival without neurosensory and cognitive outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanos, Vassilios, Pusceddu, Michele, Dessì, Angelica, Marcialis, Maria Antonietta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226612/
https://www.ncbi.nlm.nih.gov/pubmed/22189742
http://dx.doi.org/10.1590/S1807-59322011001200022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226612/
https://www.ncbi.nlm.nih.gov/pubmed/22189742
http://dx.doi.org/10.1590/S1807-59322011001200022

Ejemplares similares